PARAGON CARE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.34 AUD | 0.00% |
|
+6.25% | +51.11% |
| Mar. 18 | Paragon Care Appoints Interim CFO | MT |
| Mar. 18 | ParagonCare Appoints Interim CFO | MT |
Presenter SpeechShane Tanner (Executives)Thank you, and good morning, everyone. My name is Sha...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Paragon Care Limited is an Australia-based company. It is engaged in the supply of durable medical equipment, medical devices and consumable medical products and maintenance of technical medical equipment to the health, aged care and veterinary markets throughout Australia. Its segments include Diagnostic and Scientific, Devices, Capital and Consumables, and Service and Technology. Diagnostic and Scientific segment incorporates blood bank diagnostics manufacturer, clinical pathology diagnostics distribution and scientific and research and development (R&D) laboratory equipment distribution. Devices Segment incorporates ophthalmology and optometry, orthopedics, pain management, infection prevention and ortho biologics. Capital and Consumables segment includes medical, surgical and veterinary services. Service and Technology segment includes offering from biomedical devices to high end capital equipment, service support and technology management and service partnership with brands.
Calendar
2024-08-28
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.34
AUD
Average target price
0.31
AUD
Spread / Average Target
-8.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +51.11% | 147M | |
| -2.92% | 185B | |
| -3.80% | 107B | |
| -5.48% | 67.55B | |
| +11.22% | 54.6B | |
| +16.74% | 47.42B | |
| +3.86% | 42.24B | |
| +4.56% | 28.24B | |
| +1.64% | 26.42B | |
| +12.40% | 25.66B |
- Stock Market
- Equities
- PGC Stock
- News Paragon Care Limited
- Transcript : Paragon Care Limited - Shareholder/Analyst Call
